Affiliation:
1. National Medical Research Center for Children’s Health
2. National Medical Research Center for Children’s Health; Lomonosov Moscow State University
Abstract
In current conditions, the most effective method of preventing pneumococcal infections (PI) is vaccination, which can significantly reduce the incidence and mortality from pneumococcus and reduce the level of antibiotic resistance. The use of pneumococcal conjugate vaccines has reduced the incidence of invasive PIs in vaccinated children and unvaccinated populations. This is especially true for children with severe somatic pathology, including those with various forms of heart failure (HF). The data show that vaccination of sick HF children can be a clinically effective intervention to improve the treatment results of circulatory failure and improve patients’ quality of life. However, questions regarding the optimal timing of vaccination of sick children with heart failure, dose, frequency and strategies of vaccine introduction still need to be resolved. Data on the pathophysiology of cardioprotection provision during effective vaccination against PI, influenza and COVID-19 in cardiac pathology are summarized. The authors recommend providing conditions for effective vaccine prevention of PI in children with heart failure.
Publisher
National Medical Research Center for Childrens Health
Reference69 articles.
1. Varghese R., Jayaraman R., Veeraraghavan B. Current challenges in the accurate identification of Streptococcus pneumoniae and its serogroups/serotypes in the vaccine era. J. Microbiol. Methods. 2017; 141: 48-54. https://doi.org/10.1016/j.mimet.2017.07.015
2. Козлов Р.С., Кречикова О.И., Муравьев А.А., Миронов К.О., Платонов А.Е., Дунаева Е.А. и соавт. Результаты исследования распространенности в России внебольничной пневмонии и острого среднего отита у детей в возрасте до 5 лет (PAPIRUS). Роль S. pneumoniae и H. influenzae в этиологии данных заболеваний. Клиническая микробиология и антимикробная химиотерапия. 2013; 15(4): 246-60
3. Michelow I., Olsen K., Lozano J., Rollins N., Duffy L., Ziegler T., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics. 2017; 113(4): 701-7. https://doi.org/10.1542/peds.113.4.701
4. Manoharan A., Jayaraman R. Pneumococcal vaccines. Indian J. Med. Microbiol. 2018; 36(4): 465-74. https://doi.org/10.4103/ijmm.IJMM_18_442
5. Stacey H.L., Rosen J., Peterson J.T., Williams-Diaz A., Gakhar V., Sterling T.M., et al. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults. Hum. Vaccin. Immunother. 2019; 15(3): 530-9. https://doi.org/10.1080/21645515.2018.1532249